Sale!

CDK6 Gene Microcephaly Autosomal Recessive Type 12 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CDK6 Gene Microcephaly Autosomal Recessive Type 12 Genetic Test is a specialized diagnostic examination conducted to identify mutations in the CDK6 gene, which are linked to Microcephaly Autosomal Recessive Type 12. This condition is characterized by significantly reduced head circumference evident at birth, reflecting an underdeveloped brain. Affected individuals may also experience developmental delays and other neurological issues. The test is crucial for confirming the diagnosis, understanding the disease progression, and guiding treatment and management decisions for affected individuals and their families.

This genetic test involves analyzing the patient’s DNA to look for specific mutations in the CDK6 gene that are known to cause the disorder. Early diagnosis through genetic testing can be instrumental in managing the condition, allowing healthcare providers to offer timely interventions and support to improve the quality of life for those affected.

The test is available at DNA Labs UAE, a reputable facility known for its comprehensive range of genetic testing services. The cost of the CDK6 Gene Microcephaly Autosomal Recessive Type 12 Genetic Test is 4400 AED. Given the complexity of the test and the specialized technology required, this price reflects the resources involved in providing accurate and reliable results. Patients and families considering this test are encouraged to discuss it with their healthcare provider to understand its benefits and implications fully.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CDK6 Gene Microcephaly Autosomal Recessive Type 12 Genetic Test

At DNA Labs UAE, we offer the CDK6 Gene Microcephaly Autosomal Recessive Type 12 Genetic Test. This test is designed to diagnose individuals suspected of having CDK6 gene microcephaly, autosomal recessive type 12, a specific type of microcephaly caused by mutations in the CDK6 gene.

Test Components

  • Test Name: CDK6 Gene Microcephaly Autosomal Recessive Type 12 Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Dysmorphology
  • Doctor: Pediatrics
  • Test Department: Genetics

Pre Test Information

Before undergoing the CDK6 Gene Microcephaly Autosomal Recessive Type 12 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by CDK6 Gene Microcephaly Autosomal Recessive Type 12 NGS Genetic DNA Test gene CDK6.

Test Details

CDK6 gene microcephaly, autosomal recessive type 12 is a specific type of microcephaly characterized by an abnormally small head size. It is often associated with intellectual disability and developmental delays. NGS (Next-Generation Sequencing) genetic testing is used to analyze multiple genes simultaneously. In the case of CDK6 gene microcephaly, autosomal recessive type 12, NGS genetic testing involves sequencing the CDK6 gene to identify any mutations or changes that may be causing the condition.

NGS genetic testing is useful for providing a definitive diagnosis for individuals suspected of having CDK6 gene microcephaly, autosomal recessive type 12. It can also be used for carrier testing in families with a history of the condition, allowing individuals to determine if they carry a mutation in the CDK6 gene.

The results of NGS genetic testing can provide important information, including a better understanding of the cause of the condition, the likelihood of passing it on to future children, and potential treatment options or management strategies. It is recommended to consult with a healthcare professional or genetic counselor to fully understand the implications of the test results and to discuss any further steps or considerations.

Test Name CDK6 Gene Microcephaly autosomal recessive type 12 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CDK6 Gene Microcephaly, autosomal recessive type 12 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CDK6 Gene Microcephaly, autosomal recessive type 12 NGS Genetic DNA Test gene CDK6
Test Details

CDK6 gene microcephaly, autosomal recessive type 12 is a specific type of microcephaly that is caused by mutations in the CDK6 gene. Microcephaly is a condition characterized by an abnormally small head size and is often associated with intellectual disability and developmental delays.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced technology to analyze multiple genes simultaneously. In the case of CDK6 gene microcephaly, autosomal recessive type 12, NGS genetic testing would involve sequencing the CDK6 gene to identify any mutations or changes in the gene that may be causing the condition.

NGS genetic testing can help provide a definitive diagnosis for individuals suspected of having CDK6 gene microcephaly, autosomal recessive type 12. It can also be used for carrier testing in families with a history of the condition, allowing individuals to determine if they carry a mutation in the CDK6 gene.

The results of NGS genetic testing can provide important information for individuals and their families, including a better understanding of the cause of the condition, the likelihood of passing it on to future children, and potential treatment options or management strategies. It is important to consult with a healthcare professional or genetic counselor to fully understand the implications of the test results and to discuss any further steps or considerations.